Results 31 to 40 of about 416,102 (337)

Effect of Iron Deficiency on Glycation of Haemoglobin in Nondiabetics [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
Background: Protein glycation is a spontaneous reaction that is believed to play a key role in the pathogenesis of many clinical disorders. The glycation of proteins is enhanced by elevated glucose concentrations.
Balasubramanian Shanthi   +3 more
doaj   +1 more source

Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients

open access: yesBiomarker Insights, 2016
Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of ...
Shariq I. Sherwani   +4 more
semanticscholar   +1 more source

Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis [PDF]

open access: yes, 2015
OBJECTIVE: Glycemic variability is emerging as a measure of glycemic control, which may be a reliable predictor of complications. This systematic review and meta-analysis evaluates the association between HbA1c variability and micro- and macrovascular ...
Catherine Gorst   +18 more
core   +1 more source

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c

open access: yesJournal of Diabetes Science and Technology, 2019
Background: As the use of continuous glucose monitoring (CGM) increases, there is a need to better understand key metrics of time in range 70-180 mg/dL (TIR70-180) and hyperglycemia and how they relate to hemoglobin A1c (A1C).
R. Beck   +6 more
semanticscholar   +1 more source

HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry Findings

open access: yesDiabetes Technology & Therapeutics, 2020
Objective: The T1D Exchange Clinic Registry figure of HbA1c levels according to age has become a classic picture of how average HbA1c varies from childhood to elderly.
K. Miller, R. Beck, N. Foster, D. Maahs
semanticscholar   +1 more source

Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways [PDF]

open access: yes, 2010
OBJECTIVE Glycated hemoglobin (HbA1c), used to monitor and diagnose diabetes, is influenced by average glycemia over a 2- to 3-month period. Genetic factors affecting expression, turnover, and abnormal glycation of hemoglobin could also be associated ...
Abecasis, G   +178 more
core   +8 more sources

Validation and determination of a reference interval for Canine HbA1c using an immunoturbidimetric assay [PDF]

open access: yes, 2017
Background: Hemoglobin A1c (HbA1c) provides a reliable measure of glycemic control over 2–3 months in human diabetes mellitus. In dogs, presence of HbA1c has been demonstrated, but there are no validated commercial assays. Objective: The purpose
Goemans, Anne F.   +2 more
core   +1 more source

Add-on therapy of herbal formulation rich in standardized fenugreek seed extract in type 2 diabetes mellitus patients with insulin therapy: An efficacy and safety study

open access: yesAsian Pacific Journal of Tropical Biomedicine, 2018
Objective: To assess the safety and efficacy of herbal formulation rich in standardized fenugreek seed extract (IND-2) add-on therapy in type 2 diabetes mellitus (T2DM) patients who were on insulin treatment in prospective, single arm, open-label ...
Amit Kandhare   +4 more
doaj   +1 more source

In vitro determination of hemoglobin A1c for diabetes diagnosis and management: technology update [PDF]

open access: yes, 2014
It is fascinating to consider the analytical improvements that have occurred since glycated hemoglobin was first used in routine clinical laboratories for diabetes monitoring around 1977; at that time methods displayed poor precision, there were no ...
English, Emma   +2 more
core   +1 more source

A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice [PDF]

open access: yes, 2020
This report presents the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as initial injectable therapy at 26 weeks in the 104-week DUAL VIII durability trial (NCT02501161). Participants (N =
Aroda, V. R.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy